Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs VALIANT LABORATORIES LTD. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA VALIANT LABORATORIES LTD. CIPLA/
VALIANT LABORATORIES LTD.
 
P/E (TTM) x 26.4 -48.0 - View Chart
P/BV x 4.4 2.0 219.6% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 CIPLA   VALIANT LABORATORIES LTD.
EQUITY SHARE DATA
    CIPLA
Mar-24
VALIANT LABORATORIES LTD.
Mar-24
CIPLA/
VALIANT LABORATORIES LTD.
5-Yr Chart
Click to enlarge
High Rs1,519227 669.3%   
Low Rs886140 632.8%   
Sales per share (Unadj.) Rs319.341.9 762.1%  
Earnings per share (Unadj.) Rs51.50.1 69,901.9%  
Cash flow per share (Unadj.) Rs64.50.5 12,265.4%  
Dividends per share (Unadj.) Rs13.000-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs329.854.5 605.0%  
Shares outstanding (eoy) m807.1543.45 1,857.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.84.4 86.0%   
Avg P/E ratio x23.42,494.8 0.9%  
P/CF ratio (eoy) x18.6348.8 5.3%  
Price / Book Value ratio x3.63.4 108.3%  
Dividend payout %25.30-   
Avg Mkt Cap Rs m970,4577,971 12,175.0%   
No. of employees `000NANA-   
Total wages/salary Rs m43,10043 99,931.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m257,7411,821 14,157.2%  
Other income Rs m7,46697 7,710.1%   
Total revenues Rs m265,2071,917 13,831.6%   
Gross profit Rs m60,962-84 -72,496.5%  
Depreciation Rs m10,51020 53,459.8%   
Interest Rs m8991 115,230.8%   
Profit before tax Rs m57,019-8 -740,506.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,466-11 -142,019.3%   
Profit after tax Rs m41,5533 1,298,534.4%  
Gross profit margin %23.7-4.6 -512.1%  
Effective tax rate %27.1141.4 19.2%   
Net profit margin %16.10.2 9,183.8%  
BALANCE SHEET DATA
Current assets Rs m193,9252,255 8,598.1%   
Current liabilities Rs m52,458291 18,041.0%   
Net working cap to sales %54.9107.9 50.9%  
Current ratio x3.77.8 47.7%  
Inventory Days Days95124 76.7%  
Debtors Days Days7917 0.7%  
Net fixed assets Rs m126,8861,171 10,831.7%   
Share capital Rs m1,615435 371.6%   
"Free" reserves Rs m264,5841,934 13,679.9%   
Net worth Rs m266,1992,369 11,238.6%   
Long term debt Rs m0747 0.0%   
Total assets Rs m321,3003,427 9,375.9%  
Interest coverage x64.4-8.9 -726.3%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.80.5 151.0%   
Return on assets %13.20.1 11,393.5%  
Return on equity %15.60.1 11,568.7%  
Return on capital %21.8-0.2 -9,798.9%  
Exports to sales %22.20-   
Imports to sales %9.20-   
Exports (fob) Rs m57,150NA-   
Imports (cif) Rs m23,657NA-   
Fx inflow Rs m74,8000-   
Fx outflow Rs m23,6572 1,416,556.9%   
Net fx Rs m51,143-2 -3,062,455.1%   
CASH FLOW
From Operations Rs m41,33919 219,305.6%  
From Investments Rs m-29,880-1,439 2,076.8%  
From Financial Activity Rs m-12,0041,524 -787.4%  
Net Cashflow Rs m-490105 -468.5%  

Share Holding

Indian Promoters % 10.9 74.9 14.5%  
Foreign collaborators % 20.0 0.0 -  
Indian inst/Mut Fund % 52.9 0.0 -  
FIIs % 28.8 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 69.1 25.1 275.7%  
Shareholders   470,234 15,189 3,095.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    ZYDUS LIFESCIENCES    


More on Cipla vs VALIANT LABORATORIES LTD.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs VALIANT LABORATORIES LTD. Share Price Performance

Period Cipla VALIANT LABORATORIES LTD. S&P BSE HEALTHCARE
1-Day -0.39% 0.27% 0.11%
1-Month -3.76% -1.95% -3.22%
1-Year 16.89% -39.61% 42.65%
3-Year CAGR 17.88% -13.24% 19.86%
5-Year CAGR 24.73% -8.17% 25.90%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the VALIANT LABORATORIES LTD. share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 30.9% stake in the company. In case of VALIANT LABORATORIES LTD. the stake stands at 74.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of VALIANT LABORATORIES LTD..

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 13.0 per share. This amounted to a Dividend Payout ratio of 25.3%.

VALIANT LABORATORIES LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Cipla, and the dividend history of VALIANT LABORATORIES LTD..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.